drugset / Trial / NCT01052896
Gabapentin in Functional Dyspepsia Refractory to Proton Pump Inhibition
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to evaluate the effectiveness of gabapentin on symptom control in patients with defined functional dyspepsia refractory to conventional proton pump inhibitor therapy and to compare these effects to that of placebo.
Timeline
- Start
- 2010-03
- Primary completion
- 2011-03
- Completion
- 2012-08-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gabapentin | Small molecule | 300 mg | Oral |